[go: up one dir, main page]

Metlakunta et al., 2020 - Google Patents

Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats

Metlakunta et al., 2020

Document ID
14524515198551716171
Author
Metlakunta A
Soman R
Publication year
Publication venue
Regulatory Toxicology and Pharmacology

External Links

Snippet

Bacillus coagulans SNZ 1969 is a rod-shaped, slightly acidophilic, gram-positive, spore forming and highly resilient bacteria. B. coagulans SNZ 1969 has GRAS (Generally Recognized As Safe) status for use as a probiotic in foods (US FDA number GRN-597). The …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes

Similar Documents

Publication Publication Date Title
Wasilewski et al. Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory bowel disease
Metlakunta et al. Safety evaluation of Bacillus coagulans SNZ 1969 in Wistar rats
RU2767967C2 (en) Probiotics use for psoriasis treatment and/or prevention
ES2863398T3 (en) Use of probiotics in the treatment and / or prevention of atopic dermatitis
Kolida et al. Gastrointestinal microflora: probiotics
Jia et al. A 90-day oral toxicity study on a new strain of Lactobacillus paracasei in rats
Paliy et al. Specific composition of indigenous microflora (Lactobacillus spp., Bifidobacterium spp., Lactococcus spp.) in farm animals
EP4048299A1 (en) Probiotic composition for use as an antioxidant
RU2491079C1 (en) Composite probiotic preparation and method for preparing it
Frizzo et al. Studies on translocation, acute oral toxicity and intestinal colonization of potentially probiotic lactic acid bacteria administered during calf rearing
Sudha et al. SAFETY STUDIES OF BACILLUS COAGULANS Unique IS-2 IN RATS: MORPHOLOGICAL, BIOCHEMICAL AND CLINICAL EVALUATIONS.
Nambundunga Isolation and characterisation of bifidobacteria populations in infants in the Khomas region, Namibia
Colom et al. Presence and germination of the probiotic DE111 in the human small intestinal tract: A randomized, crossover, double-blind, and placebo-controlled study
HK40009064A (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
HK40009064B (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
EA040422B1 (en) THE USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ADOPIC DERMATITIS
OA18880A (en) Use of probiotics in the treatment and/or prevention of psoriasis
HK40000790A (en) Use of probiotics in the treatment and/or prevention of psoriasis
HK40000790B (en) Use of probiotics in the treatment and/or prevention of psoriasis